|
6-Weeks of Blood Flow Restriction Training on Immune Cell Function and Bioenergetics
RECRUITINGN/ASponsored by University of British Columbia
Actively Recruiting
PhaseN/A
SponsorUniversity of British Columbia
Started2026-02-11
Est. completion2027-12-31
Eligibility
Age19 Years – 64 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07676305
Summary
To conduct a randomized control trial to determine the impact of 6-weeks of blood flow restriction training on immune cell function and bioenergetics in adults living with type 2 diabetes.
Eligibility
Age: 19 Years – 64 YearsHealthy volunteers accepted
Inclusion Criteria: A. Aged 19-64 years. B. Diagnosed with type 2 diabetes with current HbA1c 5.7-9.0% C. Completing \<150 minutes of moderate-vigorous physical activity per week. Exclusion Criteria: A. Chronic musculoskeletal condition or recent (within 2 years) cardiovascular event preventing participation in exercise. B. Unstable type 2 diabetes medication of the last 3 months C. Absolute contraindications to BFR (i.e., peripheral vascular disease) D. A self-reported diagnosis of low iron concentrations, anemia, or being treated for these conditions E. A diagnosis of any red blood cell-altering condition (i.e., sickle cell anemia, poikilocytosis) F. Currently living with any cardiovascular disease, which would impact the ability to participate in exercise safely G. Currently prescribed any medication which would impact the ability to use a heart rate monitor to accurately track intensity
Conditions2
DiabetesType 2 Diabetes
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of British Columbia
Started2026-02-11
Est. completion2027-12-31
Eligibility
Age19 Years – 64 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07676305